Jennifer Hopkins, MD
Sleep Medicine · The Woodlands, TXNPI 1134371800
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.9%), other and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Philips North America LLC at 47.0% of the total. Reporting peaked in 2022 at $1,026 and has fallen 72.1% since, to $286 in 2025.
Across 50 payments — averaging $44.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$1K
- Inspire Medical Systems, Inc.$620
- Harmony Biosciences LLC$275
- Avadel CNS Pharmaceuticals, LLC$149
- Jazz Pharmaceuticals Inc.$60
- Azurity Pharmaceuticals, Inc.$25
- plus $54 from 3 others
What the payments were for
- Food & beverage$1,11250%
- Education$904%
- Other$1,02646%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 2 | $1,047 |
| Inspire Medical Systems, Inc. | 27 | $620 |
| Harmony Biosciences LLC | 8 | $275 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $149 |
| Jazz Pharmaceuticals Inc. | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| 3b Medical, Inc. | 2 | $16 |
| Itamar Medical Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,228 in reported general payments places this provider in the 60th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Eszopiclone | 37 | $332 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $299 |
| Zolpidem Tartrate | 47 | $274 |
| Montelukast Sodium | 11 | $150 |
| Gabapentin | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in The Woodlands
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- Ashwin GowdaAustin$71K
- John DebusDallas$38K
- Peter ObessoTyler$34K
- Karen Hentschel FranksSan Antonio$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.